These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9573199)

  • 1. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.
    Miesel L; Weisbrod TR; Marcinkeviciene JA; Bittman R; Jacobs WR
    J Bacteriol; 1998 May; 180(9):2459-67. PubMed ID: 9573199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.
    Vilchèze C; Weisbrod TR; Chen B; Kremer L; Hazbón MH; Wang F; Alland D; Sacchettini JC; Jacobs WR
    Antimicrob Agents Chemother; 2005 Feb; 49(2):708-20. PubMed ID: 15673755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
    Lee AS; Teo AS; Wong SY
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for isoniazid action and resistance.
    Miesel L; Rozwarski DA; Sacchettini JC; Jacobs WR
    Novartis Found Symp; 1998; 217():209-20; discussion 220-1. PubMed ID: 9949810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ndh gene of isoniazid resistant and susceptible Mycobacterium tuberculosis isolates from Brazil.
    Cardoso RF; Cardoso MA; Leite CQ; Sato DN; Mamizuka EM; Hirata RD; de Mello FF; Hirata MH
    Mem Inst Oswaldo Cruz; 2007 Feb; 102(1):59-61. PubMed ID: 17294000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.
    Dhandayuthapani S; Zhang Y; Mudd MH; Deretic V
    J Bacteriol; 1996 Jun; 178(12):3641-9. PubMed ID: 8655566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.
    Rawat R; Whitty A; Tonge PJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13881-6. PubMed ID: 14623976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance.
    Banerjee A; Sugantino M; Sacchettini JC; Jacobs WR
    Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2697-2704. PubMed ID: 9802011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates.
    O'Brien KL; Dietz HC; Romagnoli M; Eiden J
    Mol Cell Probes; 1996 Feb; 10(1):1-6. PubMed ID: 8684371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
    Vilchèze C; Morbidoni HR; Weisbrod TR; Iwamoto H; Kuo M; Sacchettini JC; Jacobs WR
    J Bacteriol; 2000 Jul; 182(14):4059-67. PubMed ID: 10869086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
    Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
    Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
    Vilchèze C; Jacobs WR
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.